vs
OneStream, Inc.（OS）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是OneStream, Inc.的1.2倍（$197.9M vs $163.7M），REPLIGEN CORP净利率更高（6.7% vs 0.6%，领先6.1%），OneStream, Inc.同比增速更快（23.6% vs 13.6%），OneStream, Inc.自由现金流更多（$25.6M vs $17.6M），过去两年OneStream, Inc.的营收复合增速更高（21.8% vs 14.4%）
Blue Stream面向美国佛罗里达州科勒尔斯普林斯、韦斯顿两地的居民及商业客户，提供有线电视、有线固话、数字录像服务，以及最高速率达1G的宽带互联网接入服务，深耕当地通信市场，为用户提供稳定可靠的多元通信解决方案。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
OS vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.2倍
$163.7M
营收增速更快
OS
高出9.9%
13.6%
净利率更高
RGEN
高出6.1%
0.6%
自由现金流更多
OS
多$8.1M
$17.6M
两年增速更快
OS
近两年复合增速
14.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $163.7M | $197.9M |
| 净利润 | $999.0K | $13.3M |
| 毛利率 | 69.8% | 52.5% |
| 营业利润率 | -3.2% | 9.0% |
| 净利率 | 0.6% | 6.7% |
| 营收同比 | 23.6% | 13.6% |
| 净利润同比 | — | 143.9% |
| 每股收益（稀释后） | — | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OSRGEN
| Q4 25 | $163.7M | $197.9M | ||
| Q3 25 | $154.3M | $188.8M | ||
| Q2 25 | $147.6M | $182.4M | ||
| Q1 25 | $136.3M | $169.2M | ||
| Q4 24 | $132.5M | $174.1M | ||
| Q3 24 | $129.1M | $154.9M | ||
| Q2 24 | $117.5M | $154.1M | ||
| Q1 24 | $110.3M | $151.3M |
净利润OSRGEN
| Q4 25 | $999.0K | $13.3M | ||
| Q3 25 | $-8.8M | $14.9M | ||
| Q2 25 | $-18.4M | $14.9M | ||
| Q1 25 | $-24.0M | $5.8M | ||
| Q4 24 | — | $-30.3M | ||
| Q3 24 | $-171.9M | $-654.0K | ||
| Q2 24 | $-7.8M | $3.3M | ||
| Q1 24 | $-5.0M | $2.1M |
毛利率OSRGEN
| Q4 25 | 69.8% | 52.5% | ||
| Q3 25 | 68.1% | 53.2% | ||
| Q2 25 | 68.6% | 50.0% | ||
| Q1 25 | 68.0% | 53.6% | ||
| Q4 24 | 66.8% | 26.1% | ||
| Q3 24 | 50.1% | 50.0% | ||
| Q2 24 | 68.5% | 49.8% | ||
| Q1 24 | 69.1% | 49.5% |
营业利润率OSRGEN
| Q4 25 | -3.2% | 9.0% | ||
| Q3 25 | -11.3% | 8.9% | ||
| Q2 25 | -21.8% | 7.6% | ||
| Q1 25 | -29.3% | 3.9% | ||
| Q4 24 | -35.8% | -17.7% | ||
| Q3 24 | -197.6% | -5.1% | ||
| Q2 24 | -9.8% | 1.0% | ||
| Q1 24 | -4.9% | 1.3% |
净利率OSRGEN
| Q4 25 | 0.6% | 6.7% | ||
| Q3 25 | -5.7% | 7.9% | ||
| Q2 25 | -12.5% | 8.2% | ||
| Q1 25 | -17.6% | 3.4% | ||
| Q4 24 | — | -17.4% | ||
| Q3 24 | -133.1% | -0.4% | ||
| Q2 24 | -6.7% | 2.2% | ||
| Q1 24 | -4.5% | 1.4% |
每股收益（稀释后）OSRGEN
| Q4 25 | — | $0.24 | ||
| Q3 25 | — | $0.26 | ||
| Q2 25 | — | $0.26 | ||
| Q1 25 | — | $0.10 | ||
| Q4 24 | — | $-0.55 | ||
| Q3 24 | $-1.06 | $-0.01 | ||
| Q2 24 | — | $0.06 | ||
| Q1 24 | — | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $693.6M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $504.7M | $2.1B |
| 总资产 | $1.0B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资OSRGEN
| Q4 25 | $693.6M | $767.6M | ||
| Q3 25 | $653.9M | $748.7M | ||
| Q2 25 | $652.1M | $708.9M | ||
| Q1 25 | $593.9M | $697.2M | ||
| Q4 24 | $544.2M | $757.4M | ||
| Q3 24 | $495.5M | $784.0M | ||
| Q2 24 | $140.5M | $809.1M | ||
| Q1 24 | — | $780.6M |
总债务OSRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益OSRGEN
| Q4 25 | $504.7M | $2.1B | ||
| Q3 25 | $472.1M | $2.1B | ||
| Q2 25 | $458.2M | $2.1B | ||
| Q1 25 | $412.9M | $2.0B | ||
| Q4 24 | $386.2M | $2.0B | ||
| Q3 24 | $458.2M | $2.0B | ||
| Q2 24 | $97.5M | $2.0B | ||
| Q1 24 | $102.5M | $2.0B |
总资产OSRGEN
| Q4 25 | $1.0B | $2.9B | ||
| Q3 25 | $949.4M | $2.9B | ||
| Q2 25 | $910.5M | $2.9B | ||
| Q1 25 | $867.3M | $2.9B | ||
| Q4 24 | $823.2M | $2.8B | ||
| Q3 24 | $750.1M | $2.8B | ||
| Q2 24 | $379.7M | $2.9B | ||
| Q1 24 | — | $2.8B |
负债/权益比OSRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $25.8M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $25.6M | $17.6M |
| 自由现金流率自由现金流/营收 | 15.7% | 8.9% |
| 资本支出强度资本支出/营收 | 0.1% | 4.1% |
| 现金转化率经营现金流/净利润 | 25.79× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $95.6M | $93.9M |
8季度趋势，按日历期对齐
经营现金流OSRGEN
| Q4 25 | $25.8M | $25.7M | ||
| Q3 25 | $5.0M | $48.1M | ||
| Q2 25 | $29.7M | $28.6M | ||
| Q1 25 | $36.2M | $15.0M | ||
| Q4 24 | — | $39.2M | ||
| Q3 24 | $2.4M | $49.3M | ||
| Q2 24 | $8.1M | $42.2M | ||
| Q1 24 | $25.5M | $44.7M |
自由现金流OSRGEN
| Q4 25 | $25.6M | $17.6M | ||
| Q3 25 | $4.8M | $43.4M | ||
| Q2 25 | $29.4M | $21.5M | ||
| Q1 25 | $35.8M | $11.4M | ||
| Q4 24 | — | $33.6M | ||
| Q3 24 | $1.3M | $42.3M | ||
| Q2 24 | $7.7M | $37.4M | ||
| Q1 24 | $24.9M | $36.4M |
自由现金流率OSRGEN
| Q4 25 | 15.7% | 8.9% | ||
| Q3 25 | 3.1% | 23.0% | ||
| Q2 25 | 19.9% | 11.8% | ||
| Q1 25 | 26.3% | 6.8% | ||
| Q4 24 | — | 19.3% | ||
| Q3 24 | 1.0% | 27.3% | ||
| Q2 24 | 6.6% | 24.3% | ||
| Q1 24 | 22.5% | 24.0% |
资本支出强度OSRGEN
| Q4 25 | 0.1% | 4.1% | ||
| Q3 25 | 0.1% | 2.5% | ||
| Q2 25 | 0.2% | 3.9% | ||
| Q1 25 | 0.3% | 2.1% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | 0.8% | 4.5% | ||
| Q2 24 | 0.3% | 3.1% | ||
| Q1 24 | 0.6% | 5.5% |
现金转化率OSRGEN
| Q4 25 | 25.79× | 1.93× | ||
| Q3 25 | — | 3.23× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 12.70× | ||
| Q1 24 | — | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OS
| Subscription And Circulation | $150.3M | 92% |
| Professional Services And Other | $9.4M | 6% |
| License | $4.0M | 2% |
RGEN
暂无分部数据
